A facile one pot synthesis of 2-styrylindoles, through Suzuki-arylation of ortho-substituted chloroenynes followed by N-cyclization and N-demethylation has been developed. A variety of 2-styrylindoles were obtained in good to excellent yields and were evaluated for their anticancer properties.
INTRODUCTION
Combretastatin A-4 (CA-4, Fig. 1 ) is a (Z)-stilbene isolated in 1989 by Pettit from the South African willow tree Combretum caffrum. 1 FIGURE 1. CA-4 and structural analogues This natural compound exhibited strong antitumor properties as for example, a nanomolar level of cytotoxicity against a variety of cancer cell lines including multi-drugs resistant cells. 2 Moreover at very low doses, CA-4 inhibited tubulin assembly by binding at the colchicine binding-site, 3 induced apoptosis 4 and caused in vivo spectacular vascular shutdown in established tumors. 5 In 2016, CA-4P (fosbretabulin), a phosphate water-soluble prodrug of the natural product has received the status of orphan drug in USA and Europe for the treatment of ovarian cancers, neuroendocrine tumours, certain thyroid cancers and multiform glioma. 6 Despite these excellent antitumor properties, CA-4 has some drawbacks as a poor watersolubility and a chemical instability due to the isomerization of the Z-double bond to its less active Eform during storage, administration 7 and metabolism. 8 Due to the simplicity of its chemical structure, CA-4 has been extensively studied to find more stable analogues and to establish structure-activity relationships (SARs). 9 As a part of our research program dedicated to novel stable vascular disrupting agents (VDAs) 10 having a nonisomerizable spacer between A-and B-rings, we found that isoCA-4, 10d isoerianin 11 and azaFiso-erianin 12 derivatives were as potent as CA-4 with comparable anticancer activities ( Fig. 1) . Moreover, if the replacement of the 3,4,5-trimethoxyphenyl A-ring of CA-replaced for example, by a variety of indole nuclei with no loss of biological properties. 14 For examples, it was recently showed that non-substituted N-methylindoles 12 and 3-substituted indoles 14 replaced with a certain success the traditional phenolic B-ring of CA-4. To our knowledge, introduction of styryl substituents on the C-2 position of the indole B-ring and their effects on biological activity was not reported in the CA-4 and isoCA-4 series. Due to the synthetic and biological interest for 2alkenylindoles, 15 their preparations have been well studied 16 and often, involve the alkenylation of preformed indoles by C-H functionalization 17 or by Suzuki-Miyaura coupling reactions. 18 Otherwise, 2-styrylindoles have also been prepared from 5-endo-dig-cyclizations of 2-alkynylanilines having a free NH2 function by electrochemistry or using various metal catalysts. 19 Herein, we would like to present a novel and rapid access to 2-alkenylindoles from an efficient "one pot" Suzuki arylation-heterocyclization-N-demethylation process. N,N-Dimethylanilines having on ortho-position a conjugated chloroenyne moiety were firstly arylated using different boronic acids in the presence of a catalytic amount of Pd(PPh3)4 which was re-used for the cyclization-step to furnish a small library of 2-styryl indoles after N-demethylation. After optimization of this "one pot" three-step process, the cytotoxicity of novel 2styrylindoles 1 and 2 having a trimethoxyphenyl A-ring will be discussed.
RESULTS AND DISCUSSION
The required starting material, (E)-2-(4-chlorobut-3-en-1yn-1-yl)-N,N-dimethylaniline 3a, used as a model substrate, was readily prepared by the Sonogashira coupling of 2-ethynyl-N,N-dimethylaniline with (E)-1,2dichloroethylene in 78 %. Since the treatment of chloroenyne 3 with boronic acids in the presence of suitable Pd-catalysts would lead to diarylated enynes 20 4 intermediates, we anticipated that the Pd species might activated the alkyne triple bond of intermediates 4 to provide 2-styrylindoles 5 after N-cyclization and ammonium demethylation. To identify suitable conditions for this transformation, we evaluated the Suzuki arylation / cyclization / N-demethylation reaction with (E)-chloroenyne 3a in the presence of (4-acetyl) phenylboronic acid and a variety of Pd-catalysts. The result of this study is reported in Table 1 . Initially, we have tested the conditions developed in our laboratory for the coupling of boronic acids with chloroenynes 20 using Pd(PPh3)4 (5 mol %) as the catalyst, K2CO3 (2 equiv) as the base, and toluene/MeOH (2:1) as the solvent combination at 90 °C in a sealed tube (entry 1). After 15 h of stirring and disappearance of chloroenyne (E)-3a, we isolated the desired indole (E)-5a together with diarylenyne (E)-4a in almost similar yields. This promising first result, confirming our initial hypothesis, led us to evaluate other Pd-catalysts to improve the cyclization reaction of the (E)-4a intermediate. Unfortunately, as depicted in entries 2-5, none of the Pd(0), Pd(II) catalysts as well as the third generation (G3) Buchwald pre-catalyst were able to transform (E)-3a into indole (E)-5a which was not detected in crude mixtures after 15 h of reaction. It is likely that under these conditions, the Suzuki-arylation reaction leading to 4a did not occur and that (E)-3a was completely degraded. We then decided to increase the amount of Pd(PPh3)4 quantity from 5 to 8 mol %, and we were pleased to observe the formation of indole (E)-5a, as the main product (90 %) after 48 h of reaction (entry 8). Further screening of solvents, solvent combinations and bases associated to Pd(PPh3)4 were less effective for 2-styrylindole (E)-5a generation. We also examine the efficiency of this process, under our optimized conditions, with arylated chloroenynes 3b-d (entries 9-11) having on ortho-position a free-NH2 (3b), a secondary amine (NHMe, 3c) or a NH-tosylamine (3d). In contrast to (E)-3a, none of chloroenynes 3b-d were able to provide the desired corresponding indole derivatives which were not detected in the crude complex mixtures. Using 8 mol% of Pd(PPh3)4 in the presence of 2 equiv of K2CO3 in hot toluene/MeOH mixture, chloroenyne (E)-3a reacted with various boronic acids to generate a number of 2-styrylindoles 5a-l. As depicted in Figure 2 , the reaction exhibits excellent scope: both electron-deficient and electron-rich arylboronic acids reacted efficiently to provide the desired 2-styryl indoles with high to excellent yields for this three-step "one-pot" reaction (from 71 to 92%).
FIGURE 2.
Tandem Suzuki-Miyaura cyclization reaction of (E)-chloroenyne 3a using a variety of arylboronic acids.
Substitutions are readily tolerated at all positions of the arylboronic acid substrates to provide the 2-styrylindoles in similar yields (5f-h). Introduction of heterocycles on the double bond is also permitted with this protocol since 5l was obtained in a good yield of 86 % using 2benzothiophene boronic acid as the nucleophile. The following mechanism depicted in Scheme 1 can be considered. SCHEME 1. Plausible mechanism for the synthesis of styrylindoles 5 from chloroenyne (E)-3a.
A plausible mechanism is depicted in Scheme 1 involving the formation of an indolinium salt according to a 5-endo-dig cyclization of diarylenyne 4. 21 Then, a Ndemethylation step of the indolinium by MeOH leads to styrylindole 5 and dimethylether. 22 Next, as part of our medicinal chemistry project, we next have synthesized N,N-dimethylaniline (E)-3e having a chloroenyne group on ortho-position and on paraposition a 1-(3,4,5-trimethoxyphenyl)vinyl moiety as the future A-ring (Scheme 2). A Pd-catalyzed reaction of trimethylsilylacetylene with 4bromo-2-iodo-N,N-dimethylaniline afforded trimethyl silylated (TMS)-alkyne 6 according to a Sonogashira coupling reaction (91%). SCHEME 2. Synthesis of (E)-3e. a a Conditions: (i) ArI (20 mmol Then, by using a recent methodology developed by Barluenga and co-workers, 23 diarylethylene derivative 8 was synthesized in a good yield of 86% through the palladium coupling reaction of N-tosylhydrazone 7 with 6 using Pd2dba3 as the catalyst, Xphos as the ligand and LiOtBu as the base in hot dioxane. Under these basic conditions, we were surprised to observe that the TMS group of 8 remained unchanged and was finally deprotected under classical conditions using K2CO3 in MeOH to give 9 (92%). A further Sonogashira-Linstrumelle coupling reaction with (E)-1,2dichloroethylene furnished (E)-3e (76%) as a useful platform to introduce a variety of styryl groups on the C-2 position of novel substituted indole derivatives after Pd-catalyzed arylation-cyclization reactions (Figure 3 ). By applying our optimized protocol developed for the tandem arylation-cyclization of chloroenyne (E)-3 with boronic acids, we prepared the desired indole derivatives (E)-1a-g in moderate yields due to difficulties encountered during the purification step.
Next, to synthesize a series of azaisoerianin analogues (E)-2a-d of biological interest, 3,4,5-trimethoxy-Nmethylaniline was coupled with alkyne 6 under Pdcatalysis to give tertiary amine 10 (83%). After a desilylation step of the alkyne function of 10, the resulting terminal alkyne 11 (90%) was then coupled with (E)-1,2-dichloroethylene to give (E)-3f in an acceptable yield of 66%. This later was then transformed into the desired indoles 2a-d using this novel Suzukicyclization-N-demethylation process with good yields (from 74% to 82%) for the three steps (Scheme 3). In vitro cytotoxicity of the newly synthesized indole derivatives 1 and 2 was investigated against HCT116, a human colon carcinoma cell line. A colorimetric-based assay was used to determine the drug concentration required to inhibit cell growth by 50% (GI50) after incubation in the culture medium for 72 h. IsoCA-4 was included as the reference for comparisons. The screening revealed that all newly synthesized indole derivatives 1 and 2 evaluated against HCT cancer cell lines displayed an average level of cytotoxicity when compared with isoCA-4 ( Table 2 ). The comparison of the GI50 values obtained for compounds 1 and 2 clearly revealed that 1,1diarylethylenes derivatives 1a-g displayed a promising sub-micromolar level of cytotoxicity (0.18 M < GI50 < 0.74 M) whereas their N-Methyl analogues 2a-d displayed a lower level of cytotoxicity with GI50 values ranging from 1.32 to 4.08M. The cytotoxic of promising derivatives 1c and 1e having respectively a p-methoxy and a m-NO2 group on their aromatic rings displayed encouraging GI50 values (0.26 M for 1c and 0.18 M for1e.) will be furthermore modified in our lab in view of possible improvements of cytotoxicity against a range human cancer cell lines. To examine if the cytotoxicity of compounds 1 and 2 was related to an interaction with the microtubule system, indoles 1 and 2 were next evaluated in tubulin assembly assays in parallel with isoCA-4 (Table 2 ). However, 1c and 1e which displayed the best cytotoxicity level against HCT116 cells inhibited tubulin assembly with modest GI50 values comparable to the GI50 of all other indole derivatives 1 and 2. Currently, we are working to improve the cytotoxicity of derivatives 1 through the introduction of more suitable substituents.
CONCLUSION
In summary, we have discovered a novel 3-steps Suzuki-Miyaura arylation / cyclization / N-demethylation of (E)-2-(4-chlorobut-3-en-1-yn-1-yl)-N,N-dimethylanilines, giving an efficient and rapid access to 2-styrylindoles with good to excellent yields. Using this strategy, we have rapidly achieved the synthesis of a series of 1,1diarylethylenes 1 and diarylmethylamines 2 bearing a 3,4,5-trimethoxyphenyl core and various functionalized 2-styrylindoles as isoCA-4 and azaisoerianin analogues. From the preliminary biological results, indoles 1c and 1e were the most promising compounds with nanomolar GI50 values. Structural modifications on the indole nucleus are currently under study in our laboratory and will be published later. E)-2-(4-Chlorobut-3-en-1-yn-1-yl)-N,N- (E)-2-(4-Chlorobut-3-en-1-yn-1-yl)-N,N-dimethyl-4-(1-(3,4,5-trimethoxyphenyl) 2-(4-Chlorobut-3-en-1-yn-1-yl)-N 1 ,N 1 ,N 4 -trimethyl  -N 4 -(3,4,5-trimethoxyphenyl Procedure for the synthesis of (E)-chloroenynes 3c.
EXPERIMENTAL SECTION
To a solution of 3b (5 mmol, 888 mg) in DMF (30 mL) was added K2CO3 (1.5 equiv) and iodomethane (1.1 equiv). The reaction was stirred at room temperature for 3 h then quenched with water (30 mL). The aqueous layer was extracted with CH2Cl2 three times and the combined organic extracts were dried with anhydrous MgSO4, filtered and concentrated. The crude mixture was purified by silica gel column chromatography (0 to 30% AcOEt in cyclohexane).
( E)-2-(4-Chlorobut-3-en-1-yn-1-yl Cl: 192.0580; found: 192.0570 . Procedure for the synthesis of (E)-chloroenynes 3d.
A solution of 4-methylbenzene-1-sulfonyl chloride (1 equiv) in THF (20 mL) was added dropwise over 0.5 h to a solution of 3b (5 mmol) and pyridine (1.1 equiv) in THF (30 mL) under argon. The solution was stirred at r.t. for 12 h. The resulting mixture was evaporated under vacuum and the residue was purified by silica gel column chromatography (0 to 30% AcOEt in cyclohexane). N-(2-(4-Chlorobut-3-en-1-yn-1-yl) Under argon, chloroenyne (0.5 mmol), the desired boronic acid (1.3 equiv), K2CO3 (2 equiv), and Pd(PPh3)4 (8 mol%) were mixed in toluene (6 mL) and MeOH (3 mL) . The reaction mixture was stirred at 90°C in 30 mL sealed tube monitored by TLC (48 h) . After the mixture were allowed to cool to room temperature and filtrated through a pad of celite washed by CH2Cl2. Solvent was removed under reduced pressure and the crude material was purified by silica gel column chromatography (0 to 30% AcOEt in cyclohexane).
(E)-

(E)-1-(4-(2-(1-Methyl-1H-indol-2-yl)vinyl)phenyl) ethan-1-one (5a)
Yellow solid, mp 188.5 -188.9 °C, yield 90%, 123.9 mg. 1 
